What are the most promising leading biopharmaceutical stocks?
Specializing in biopharmaceutical research and development, production and sales, with leading technology and brand advantages, is committed to providing high-quality, safe and effective medical products and services for patients around the world. The following editorial brings the most potential leading biopharmaceutical stocks which are of great benefit to you, take a look together.
Most Potential Biomedical Leading Stocks
Potential Biomedical Leading Stocks are as follows:
1.Hengrui Pharmaceuticals (600276), the first stock of domestic innovative drugs. The main product lines are anti-tumor, anesthesia, contrast agents and so on. The company's return on net assets for many years to maintain more than 23%, net profit for many years to maintain a rate of growth of more than 20%. The company's R&D strength is very strong, the management team is relatively good, and the sales capacity is also very strong.
2. Aier Ophthalmology (300015), the first share of domestic ophthalmic hospital chain. Mainly to provide patients with a variety of ophthalmic diseases diagnosis, treatment and medical optometry and other ophthalmic medical services. The company's return on net assets for many years to maintain at about 20%, net profit for many years to maintain a rate of growth of more than 30%.
3. Myriad Medical (300760), the first domestic medical device stocks. The main product lines are life and information support, in vitro diagnostics, medical imaging and so on. The company's return on net assets for many years to maintain more than 25%, net profit for many years to maintain a rate of growth of more than 25%.
What are the leading biomedical medical stocks
Leading pharmaceutical stocks are:Fuxiang Pharmaceuticals (300497), Minova (603538), Zixin Pharmaceuticals (002118). Below is a detailed description of these stocks, interested investors can continue reading. Among them, Menovar is one of the most exported specialty API domestic companies in Europe.
Leading stock name leading stock code belongs to the plate industry category associated reason Fuxiang Pharmaceuticals 300497 GEM Pharmaceuticals and Biologicals β- the world's mainstream supplier of endocannabinoid enzyme inhibitors; the main production of specialty antimicrobial raw materials and their intermediates, including the series of sulbactam and tazobactam series β- the three major series: endocannabinoid enzyme inhibitor APIs and intermediates, as well as carbapenem antimicrobial APIs and intermediates. Among them, tazobactam and sulforaphane sulfonate are APIs, and the others are intermediates. 2019 revenue was 59.8 billion yuan.7% of the main business. Minova 603538 Shanghai Pharmaceuticals and Biologicals exports the most specialty APIs to Europe One of the domestic companies successfully developed and produced APIs and intermediates for sartan, resuvastatin, atorvastatin, clopidogrel, and esomeprazole; Liaoyuan Pharmaceuticals targeted products for cardiovascular, antidepressant, and psychoactive APIs and drug intermediates; and Krka, dd and Novomesto A joint venture was established with revenues of $974 million from intermediates and APIs in 2019, accounting for $8.2 billion.5% of the main business. Zixin Pharmaceuticals 002118 SME Pharmaceuticals and Biologicals National secondary protection of traditional Chinese medicine has for 3 kinds. Zixin Pharmaceutical 002118 small and medium-sized board of medicine and biology national secondary protection of traditional Chinese medicine has for three kinds. The products mainly include four wonderful pills, Huo bile tablets, kidney fukang capsule, blood circulation and vein tablet, split pill, Erding granules, children's white shellfish, and so on. , which are used to treat rheumatism, ear, nose and throat, urinary system, cardiovascular, cerebrovascular, liver and gallbladder, and digestive system diseases; the former includes white ginseng, red ginseng, dried ginseng, ginseng biloba beverage, ginseng fruit and vegetable fermented beverage, etc. Since 2019, ginseng product revenues have been US$384 million, accounting for US$4.4 billion.7% of the revenue from proprietary Chinese medicines products was 4%.6 billion, accounting for US$5.4 billion.1%.
What are the leading stocks of listed pharmaceutical companies
The leading stocks of listed pharmaceutical companies are Tencent Holdings Limited, WuXi Biologics, and China Biopharmaceutical.
1, Tencent Holdings Limited (00700.HK): Tencent's pharmaceutical subsidiary Tencent Healthcare is one of China's leading Internet healthcare platforms, and is one of the leading companies in the pharmaceutical industry.
2. WuXi Biologics (02269.HK): a biopharmaceutical company focusing on innovative drug development, is one of the largest drug development outsourcing service providers in China.
3, WuXi Biologics (02269.HK): a biopharmaceutical company focusing on innovative drug R&D and is one of the largest drug R&D outsourcing service providers in China.
Pharmaceutical Stocks Leading Stocks Ranking Top 10
Pharmaceutical sector each leading stocks list:
1. Pharmaceuticals total leader: 600276 Hengrui Medicine
2. Traditional Chinese medicine total leader: 000538 Yunnan Baiyao
3. New drug experimental leader: 603259 Pharmacopeia
4. Diabetes leader: 600867 Tonghua Dongbao
5. I.V. infusion leader: 002422 Kelun Pharmaceuticals
6. Vitamin drug leader: 002001 Xinhecheng
7. Blood products leader: 002007 Hualan Bio
8. Growth hormone leader: 000661 Changchun High-Tech
9. Central nervous system leader: 002262 Enhua Pharmaceutical
10. Ophthalmology services leader: 300015 Aier Ophthalmology
11. Dental services leader: 600763 Tongze Medical
12. Paste medicine leader: 002287 Qizheng Tibetan medicine
13. Nuclear medicine leader: 002675 Dongcheng Pharmaceutical
14. p>
14. Pharmaceutical business leader: 601607 Shanghai Pharmaceuticals
15. Household medical equipment leader: 002223 Yuyue Medical
Listed companies in the biomedical sector of what stocks
Tiantan Biological, Guangshengtang, Dongbao Biological, is the sea of biological, Lexin Medical and so on.
1, Tiantan Biological
The full name of the company is Beijing Tiantan Biological Products Company Limited (referred to as "Tiantan Biological"), and its listed stock is Tiantan Biological (600161). It is an enterprise engaged in the research, production and operation of vaccines, blood preparations, diagnostic supplies and other biological products, and was listed on the Shanghai Stock Exchange in 1998 by the Beijing Institute of Biological Products, and now the controlling shareholder is China National Biotechnology Corporation.
2, Guangshengtang
The company's full name is Fujian Guangshengtang Pharmaceutical Co. Its listed stock is Guangshengtang (300436), is a collection of drug research and development, production, sales in one of the modern pharmaceutical enterprises, GMP certification of modern factories.
3, Dongbao Biological
The company's full name is Baotou Dongbao Biotechnology Co., Ltd. was founded in 1997, its listed stock is Dongbao Biological (300239), is specialized in the production of gelatin and extended products collagen production enterprises. State-level high-tech enterprises, Inner Mongolia private enterprise 50, in 2011 in Shenzhen A shares successfully listed. Mainly engaged in gelatin series products, collagen and calcium phosphate.